L-Carnitine Prevents Behavioural Alterations in Ketamine-Induced Schizophrenia in Mice: Possible Involvement of Oxidative Stress and Inflammation Pathways
Open Access
- 16 June 2023
- journal article
- research article
- Published by Wiley in Journal of Toxicology
- Vol. 2023, 1-12
Abstract
Schizophrenia is a chronic mental complaint known as cognitive impairment. There has been evidence that inflammation and oxidative stress play a main role in schizophrenia pathophysiology. This study aimed to investigate the effects of l-carnitine, as a potent antioxidant, on the treatment of behavioural and biochemical disturbances in mice with ketamine-induced schizophrenia. In this study, schizophrenia was induced in mice by ketamine (25mg/kg/day, i.p). Before induction of schizophrenia, mice were treated with l-carnitine (100, 200, and 400mg/kg/day, i.p). Then, behavioural impairments were evaluated by open field (OF) assessment and social interaction test (SIT). After brain tissue isolation, reactive oxygen species (ROS), glutathione concentration (GSH), lipid peroxidation (LPO), protein carbonyl oxidation, superoxide dismutase activity (SOD), and glutathione peroxidase activity (GPx) were assessed as oxidative stress markers. Furthermore, inflammatory biomarkers such as tumour necrosis factor alpha (TNF-α) and nitric oxide (NO) were evaluated in brain tissue. Our results showed ketamine increased inflammation and oxidative damage in brain tissue that was similar to behaviour disorders in mice. Interestingly, l-carnitine significantly decreased oxidative stress and inflammatory markers compared with ketamine-treated mice. In addition, l-carnitine prevented and reversed ketamine-induced alterations in the activities of SOD and GPx enzymes in mices brains. Also, improved performance in OFT (locomotor activity test) and SIT was observed in l-carnitine-treated mice. These data provided evidence that, due to the antioxidant and anti-inflammatory effects of l-carnitine, it has a neuroprotective effect on mice model of schizophrenia.Keywords
Funding Information
- Mazandaran University of Medical Sciences (1232, 105)
This publication has 89 references indexed in Scilit:
- Free radicals, antioxidant defense systems, and schizophreniaProgress in Neuro-Psychopharmacology and Biological Psychiatry, 2013
- Oxidative stress in schizophrenia: An integrated approachNeuroscience & Biobehavioral Reviews, 2011
- Early signs, diagnosis and therapeutics of the prodromal phase of schizophrenia and related psychotic disordersExpert Review of Neurotherapeutics, 2010
- Neuroprotection by Acetyl-L-Carnitine after Traumatic Injury to the Immature Rat BrainDevelopmental Neuroscience, 2010
- Protective Effect of L-Carnitine and Coenzyme Q10 on CCl4-Induced Liver Injury in RatsScientia Pharmaceutica, 2010
- Carnitine homeostasis, mitochondrial function and cardiovascular diseaseDrug Discovery Today: Disease Mechanisms, 2009
- Dietary l-carnitine supplementation enhances the lipopolysaccharide-induced acute phase protein response in broiler chickensVeterinary Immunology and Immunopathology, 2007
- Antioxidant and antiradical activities of l-carnitineLife Sciences, 2006
- Is schizophrenia an immunologic receptor disorder?Medical Hypotheses, 1983
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976